ResearcherFudan UniversityActive in the last 2 years
Haokang Feng
Matched on OpenAlex author ID A5113091997. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2025: 4 papers
Papers 4
- Targeting annexin A2 enhances anti-PD-1 immunotherapy in pancreatic ductal adenocarcinoma by remodeling the tumor immune microenvironment. Co-author DOI 10.1016/j.intimp.2025.115504↗
- Unveiling circulating targets in pancreatic cancer: Insights from proteogenomic evidence and clinical cohorts. Co-author DOI 10.1016/j.isci.2024.111693↗
- Deciphering molecular crosstalk mechanisms between skeletal muscle atrophy and KRAS-mutant pancreatic cancer: a literature review. Co-author DOI 10.21037/hbsn-24-282↗
- Metagenomic Microbial Signatures for Noninvasive Detection of Pancreatic Cancer. Co-author DOI 10.3390/biomedicines13041000↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xu Han · 2 shared papers, 2025 · strength 0.43
- Paper Deciphering molecular crosstalk mechanisms between skeletal muscle atrophy and KRAS-mutant pancreatic cancer: a literat… DOI 10.21037/hbsn-24-282↗
- Paper Unveiling circulating targets in pancreatic cancer: Insights from proteogenomic evidence and clinical cohorts. DOI 10.1016/j.isci.2024.111693↗
- Huaxiang Xu · 2 shared papers, 2025 · strength 0.43
- Paper Deciphering molecular crosstalk mechanisms between skeletal muscle atrophy and KRAS-mutant pancreatic cancer: a literat… DOI 10.21037/hbsn-24-282↗
- Paper Unveiling circulating targets in pancreatic cancer: Insights from proteogenomic evidence and clinical cohorts. DOI 10.1016/j.isci.2024.111693↗
- Yuquan Guo · 2 shared papers, 2025 · strength 0.43
- Paper Deciphering molecular crosstalk mechanisms between skeletal muscle atrophy and KRAS-mutant pancreatic cancer: a literat… DOI 10.21037/hbsn-24-282↗
- Paper Unveiling circulating targets in pancreatic cancer: Insights from proteogenomic evidence and clinical cohorts. DOI 10.1016/j.isci.2024.111693↗
- Yueying Chen · 1 shared paper, 2025 · strength 0.27
- Ling Dong · 1 shared paper, 2025 · strength 0.27
- Maozhen Peng · 1 shared paper, 2025 · strength 0.26
- Mengmeng Liu · 1 shared paper, 2025 · strength 0.26
- Chao Song · 1 shared paper, 2025 · strength 0.26
- Yaolin Xu · 1 shared paper, 2025 · strength 0.22
- Weisheng Yu · 1 shared paper, 2025 · strength 0.22
- Dansong Wang · 1 shared paper, 2025 · strength 0.22
- Wenhui Lou · 1 shared paper, 2025 · strength 0.22
- Jianang Li · 1 shared paper, 2025 · strength 0.21
- Hanlin Yin · 1 shared paper, 2025 · strength 0.21
- Liang Liu · 1 shared paper, 2025 · strength 0.21
- Hua Su · 1 shared paper, 2025 · strength 0.21
- Lei Zhang · 1 shared paper, 2025 · strength 0.21
- Runjie Liu · 1 shared paper, 2025 · strength 0.21
- Wenhui Lou · 1 shared paper, 2025 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.